CVS Health Corporation with ticker code (CVS) now have 23 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between $104.00 and $74.00 with the average target price sitting at $87.39. Given that the stocks previous close was at $78.82 this would imply there is now a potential upside of 10.9%. The 50 day moving average now sits at $71.13 while the 200 day moving average is $71.23. The total market capitalization for the company now stands at 101.63B. The current share price for the company is: $78.97 USD
The potential market cap would be $112,676,216,645 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 12.09, revenue per share of $268.63 and a 3.64% return on assets.
CVS Health Corporation, together with its subsidiaries, is a diversified health solutions company. The Company’s segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. Its Health Care Benefits offer a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare supplement plans, and Medicaid health care management services. Its Health Services provides a full range of pharmacy benefit management solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, and diagnostic testing.
